Actinium Pharmaceuticals Inc (ATNM)
9.68
-0.12
(-1.22%)
USD |
NYAM |
May 20, 16:00
9.68
0.00 (0.00%)
After-Hours: 20:00
Actinium Pharmaceuticals Accounts Payable (Quarterly)
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2019 | 4.598M |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | 4.650M |
| September 30, 2017 | 3.45M |
| June 30, 2017 | 3.605M |
| March 31, 2017 | 4.769M |
| December 31, 2016 | 4.195M |
| September 30, 2016 | 2.571M |
| June 30, 2016 | 1.379M |
| March 31, 2016 | 1.853M |
| December 31, 2015 | 1.474M |
| September 30, 2015 | 0.8885M |
| June 30, 2015 | 1.011M |
| March 31, 2015 | 1.248M |
| December 31, 2014 | 2.284M |
| September 30, 2014 | 1.731M |
| June 30, 2014 | 1.045M |
| March 31, 2014 | 0.6153M |
| December 31, 2013 | 0.379M |
| Date | Value |
|---|---|
| September 30, 2013 | 0.312M |
| June 30, 2013 | 0.7936M |
| March 31, 2013 | 0.4599M |
| December 31, 2012 | 0.897M |
| September 30, 2012 | 0.00 |
| June 30, 2012 | 0.00 |
| March 31, 2012 | 0.001M |
| December 31, 2011 | 0.6445M |
| September 30, 2011 | 0.0015M |
| June 30, 2011 | 0.00 |
| March 31, 2011 | 0.0115M |
| December 31, 2010 | 0.0137M |
| September 30, 2010 | 0.0122M |
| June 30, 2010 | 0.0108M |
| March 31, 2010 | 0.0115M |
| December 31, 2009 | 0.0135M |
| September 30, 2009 | 0.0099M |
| June 30, 2009 | 0.0116M |
| March 31, 2009 | 0.0101M |
| December 31, 2008 | 0.0124M |
| September 30, 2008 | 0.0095M |
| June 30, 2008 | 0.0095M |
| March 31, 2008 | 0.0092M |
| December 31, 2007 | 0.0024M |
| September 30, 2007 | 0.00 |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
4.598M
Minimum
Dec 2019
4.598M
Maximum
Dec 2019
4.598M
Average
4.598M
Median
Dec 2019
Accounts Payable (Quarterly) Benchmarks
| Perspective Therapeutics Inc | 6.027M |
| Eli Lilly and Co | 2.474B |
| Cellectar Biosciences Inc | -- |
| Outlook Therapeutics Inc | 4.363M |
| Bristol-Myers Squibb Co | 3.539B |